ODOlga Dicusar

Olga Dicusar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olga Dicusar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The role of inflammation and anti-inflammatory therapy in non-obstructive coronary artery disease (NOCAD)

    by Victoria Tofan, Mihail Popovici, Svetlana Cojocari, Victoria Ivanov, Mihaela Munteanu, Olga Dicusar, Diana Turlacova

    A large proportion of patients undergoing coronary angiography for angina pectoris do not have obstructive epicardial coronary arteries (ANOCA). In these patients, the prevalence of demonstrable ischemia (INOCA) varies between 10% and 30%, depending on the stress test performed. In recent years, research has focused on defining, classifying, and treating these patients according to INOCA endotypes. Inflammation and endothelial dysfunction play a key role in the onset and progression of chronic non-obstructive coronary artery disease (non-obstructive CAD), and identifying the correlation between these mechanisms and the disease itself may offer a targeted therapeutic strategy. This synthesis presents data from the last 10 years of the specialized literature, searched on Google Scholar and PubMed using keywords such as: inflammation in non-obstructive CAD, anti-inflammatory therapy in non-obstructive CAD. The selected studies, with scientific relevance, focused on the clinical importance, mechanism, evaluation, and management of non-obstructive CAD, with particular emphasis on the role of inflammation, endothelial dysfunction, and anti-inflammatory therapy

  • Open Access

    Rate, clinical and management characteristics of patients with chronic non-obstructive coronary artery disease (NOCAD)

    by Olga Dicusar, Victoria Tofan, Diana Turlacova, Mihaela Munteanu, Mihail Popovici, Victoria Ivanov, Ion Popovici, Lucia Ciobanu

    Purpose: To assess the rate of non-obstructive CAD among patients with stable coronary artery disease and to evaluate the clinical, diagnostic and treatment features of this population. Material and Methods: The operative protocols and medical records of 3,200 patients who underwent coronary angiography in two cardiac catheterization centers in Moldova between January 1 and August 1, 2024, were analyzed to determine the rate of non-obstructive CAD. Clinical, demographic, diagnostic, and treatment data were collected from 200 consecutive patients with non-obstructive CAD. Results: The calculated rate of non-obstructive CAD was 43.4%, with a female predominance of 61%. The mean age of patients was 64.7±8.8 years. The most common risk factors were hypertension (87%) and dyslipidemia (73%), while diabetes mellitus was diagnosed in 26%. Only 47% of patients reported typical angina pain, and just 23% had objective evidence of ischemic changes on non-invasive testing. Microvascular angina was diagnosed in 69% of cases, and vasospastic angina in 6%. Antianginal treatment included beta-blockers (69%), calcium channel blockers (52%), nitrates (4%), and trimetazidine (8%). Baseline therapy included ACE inhibitors (77%), statins (72%) and antiplatelets (49%). Conclusions: The rate of non-obstructive CAD evaluated in two PCI centers in Moldova was 43.4%, with a predominance of women accounting for 61%. The diagnosis of non-obstructive CAD presents a challenge for clinicians due to the atypical clinical presentation (typical anginal pain in only 47% of cases), non-informative non-invasive tests (objective evidence of ischemic changes detected non-invasively in 23% of cases), and the unavailability of invasive coronary testing.

  • Open Access

    Endothelial dysfunction in patients with non-ST-segment elevation myocardial infarction

    by Olga Dicusar, Petru Liuba, Mihail Popovici, Victoria Ivanov

    Purpose: Evaluation of peripheral endothelial function using EndoPAT 2000 device in patients with non-ST-eleva-tion myocardial infarction (NSTEMI) and correlation with clinical characteristics of the patients.Material and methods: The study included 39 patients with NSTEMI, hospitalized in 2 PCI centers, in the period 03.2022-03.2023. At 72 hours after admission, peripheral endothelial function was assessed using the EndoPAT 2000 device. Patients were divided into 2 groups according to the presence of peripheral endothelial dysfunction (RHI 1.67), and group II – 20 patients with endothelial dysfunction (RHI<1.67). In the group of patients with endothelial dysfunction, twoor three-vessel disease prevailed (χ2=2.7, p=0.43) and a higher rate of coronary angioplasty was recorded (χ2=4.36, p=0.037). Conclusion: Peripheral endothelial dysfunction estimated by the EndoPat 2000 method is identified in 51,3% of patients with NSTEMI. The endothelial dysfunction correlated with severity of coronary lesions. Further studies are neededto assess the diagnostic and prognostic value of the method.

  • Open Access

    Management of patients with acute myocardial infarction without ST-segment elevation in the Republic of Moldova

    by Mihail Popovici, Victoria Ivanov, Olga Dicusar, Ion Moraru, Lucia Ciobanu, Ion Popovici, Tatiana Dănilă, Carolina Dumanschi, Stela Fuior, Victoria Tofan, et al.

    Purpose: To evaluate the quality of NSTEMI care in AMI centers and to identify potential gaps in the management of patients with this diagnosis.Material and methods: 550 patients with NSTEMI, hospitalized in 3 coronary angioplasty centers were enrolled in the study. The information was collected using a questionnaire composed of 179 questions, developed according to the standards of the EORP NSTEMI Registry. The research took place in two stages: retrospective observational study during 2019 and prospective in the period 01.2020-09.2022.Results. The NSTEMI rate from the total number of patients hospitalized with AMI in the Institute of Cardiology and SP Novamed, in the period 2019-2022 was 21,6%. The results of the evaluation of NSTEMI management in the studied AMI centers are close to those reported by equivalent international registries (EORP NSTEMI, FAST-MI, PLACS, MINAP), excepting some differences in certain chapters: the diagnostic strategy of NSTE-ACS, risk stratification, diagnosis and treatment of hypercholesterolemia and the antiplatelet treatment indicated at discharge. The mortality rate in the hospital was 4,2%, at 30 days m8k6,0%, at 6 months after hospitalization 10,2%, and at 12 months 12,8%. Conclusions. The rate of NSTEMI in the Republic of Moldova is lower than that reported by the international registers of IMA, while the mortality indicators are higher. These discrepancies are largely explained by gaps in NSTEMI management identified within the studied AMI centers.